Draft Guidance More Than Meets The Eye? Senators Seek Answers From FDA
This article was originally published in The Tan Sheet
Executive Summary
Republicans on the Senate HELP Committee say they are concerned that FDA is using draft guidance documents to set substantive policy, putting companies in a difficult position.
You may also be interested in...
FDA Guidances Aim For Better Accuracy In OTC, Professional Glucose Meters
The agency for the first time issued distinct guidance documents for blood glucose meters used in professional settings and those issued over-the-counter for self-monitoring tests by lay-people. FDA is collecting comments on draft versions of the guidelines.
Industry Involvement In Guidance Development Encouraged By FDA Working Group
In a report on best practices for guidance development, FDA encourages outside groups to submit their own draft guidance proposals to help make the overall process more efficient.
FDA Eyes Upclassification, Labeling Guidance To Address Stapler Risks
The US agency sent a letter to health-care providers spotlighting its analysis of the increasing numbers of adverse events linked to surgical staplers and implantable staples, and its plans for a draft guidance on labeling and an advisory panel meeting to consider a 510(k) requirement for the products.